Comment
doi: 10.1111/ajt.14983.
Epub 2018 Jul 27.
HHV-6 and septic shock: Tenuous proof of causation
Affiliations
- PMID: 29939480
- DOI: 10.1111/ajt.14983
Item in Clipboard
Comment
HHV-6 and septic shock: Tenuous proof of causation
Am J Transplant.
2019 Jan.
Free article
No abstract available
Keywords: editorial; hepatology; infection and infectious agents; infection and infectious agents - viral; infection and infectious agents - viral: human herpesvirus 6 (HHV-6); infectious disease; liver transplantation; personal viewpoint.
Comment in
-
Need for a better characterization of HHV-6 infections and associated clinical impacts.Am J Transplant. 2019 Jan;19(1):304-305. doi: 10.1111/ajt.15013. Epub 2018 Aug 1. Am J Transplant. 2019. PMID: 29985560 No abstract available.
-
Antiviral therapy for the treatment of HHV-6-associated syndromes after transplant.Am J Transplant. 2019 Jan;19(1):306-307. doi: 10.1111/ajt.15069. Epub 2018 Sep 12. Am J Transplant. 2019. PMID: 30102463 No abstract available.
Comment on
-
Fatal outcome after reactivation of inherited chromosomally integrated HHV-6A (iciHHV-6A) transmitted through liver transplantation.Am J Transplant. 2018 Jun;18(6):1548-1551. doi: 10.1111/ajt.14657. Epub 2018 Jan 27. Am J Transplant. 2018. PMID: 29316259
-
Effects of Prophylactic Foscarnet on Human Herpesvirus-6 Reactivation and Encephalitis in Cord Blood Transplant Recipients: A Prospective Multicenter Trial with an Historical Control Group.Biol Blood Marrow Transplant. 2018 Jun;24(6):1264-1273. doi: 10.1016/j.bbmt.2018.02.008. Epub 2018 Feb 15. Biol Blood Marrow Transplant. 2018. PMID: 29454651 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
